Left ventricular hypertrophy in children and adolescents before and after kidney transplantation

Insights

Left ventricular hypertrophy (LVH) remains prevalent in children post-kidney transplantation (KTx). While LVH is common, its reversibility is challenging, emphasizing the need for strict blood pressure control to manage left ventricular mass index (LVMI).

Area of Science:

  • Pediatric Nephrology
  • Cardiology in Chronic Kidney Disease
  • Transplantation Medicine

Background:

  • Left ventricular hypertrophy (LVH) is a significant risk factor for premature mortality in pediatric patients with chronic kidney disease (CKD).
  • Understanding the progression and reversibility of LVH after kidney transplantation (KTx) is crucial for improving long-term outcomes.
  • The study investigates changes in left ventricular mass index (LVMI) following successful KTx in children.

Purpose of the Study:

  • To evaluate the changes in left ventricular mass index (LVMI) in children undergoing successful kidney transplantation (KTx).
  • To assess the prevalence and potential reversibility of left ventricular hypertrophy (LVH) after KTx.
  • To identify clinical variables associated with LVMI in pediatric kidney transplant recipients.

Main Methods:

  • Retrospective analysis of 25 pediatric patients who underwent successful KTx at a tertiary nephrology center.
  • Longitudinal assessment of left ventricular mass index (LVMI) using echocardiography before and after KTx.
  • Evaluation of risk factors, including systolic hypertension, associated with LVH.

Main Results:

  • The prevalence of LVH was 23.5% during chronic dialysis and increased to 29.4% post-KTx (p=0.06).
  • Significant individual variations in LVMI were observed pre- and post-transplantation.
  • Uncontrolled systolic hypertension was identified as a significant risk factor associated with LVMI (p=0.03).

Conclusions:

  • Left ventricular hypertrophy (LVH) is a common finding in children after kidney transplantation (KTx).
  • Reversibility of established LVH appears challenging in this population.
  • Effective management of systolic hypertension and other risk factors is essential for modifying LVMI and improving cardiovascular health in pediatric kidney transplant recipients.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
68
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
82
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
82
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
75
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
90